Latest Strategies for Chronic Migraine Control

You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!

Key Questions
  • How many people in the world have what’s considered chronic migraine?
  • When and how does chronification of migraine start?
  • What’s the difference between chronic migraine and medication overuse headache?
  • Is medication overuse a cause of or an exacerbating factor for chronic migraine?
  • What are some of the risk factors for episodic migraine to progress to chronic migraine?
  • What are some of the indications that someone might have transitioned to chronic migraine?
  • Why do patients tend to underreport their frequency of migraine?
  • What are some of the barriers to appropriate diagnosis of chronic migraine?
  • What advice do you give patients who say that triptans are the only thing that works for them, but they are afraid of rebound headaches?
  • What are some nonmedicinal treatments, tools, or therapies that might help people avoid or treat chronic migraine?
  • What do you tell a patient who says they have tried everything but nothing works?
  • What resources are there for people with chronic migraine who are frustrated and overwhelmed with navigating the health care system along with the condition itself?
  • How can people with migraine be proactive in treating their condition?
Interview Notes

Carrie Dougherty, MD, FAHS

Associate Professor of Neurology
MedStar Georgetown University Hospital

Carrie Dougherty, M.D., is an associate professor of neurology and program director of the headache medicine fellowship at MedStar Georgetown University Hospital in Washington, D.C. She received her medical degree from Indiana University School of Medicine, followed by an internship at NorthShore University HealthSystem in Evanston, IL. Dr. Dougherty completed her neurology residency at Georgetown University Medical Center in Washington, D.C., followed by a fellowship in headache medicine at Thomas Jefferson University in Philadelphia, PA. She is board certified in neurology, with subspecialty certification in headache medicine.

Dr. Dougherty is a fellow of the American Headache Society and serves as a member of the guidelines committee and the Scottsdale Headache Symposium planning committee. She is a 2019 graduate of the AHS Emerging Leaders Program.  She is on the board of the Southern Headache Society and the Alliance for Headache Disorders Advocacy.  She is committed to improving the lives of her patients through her clinical work, as well as through education and advocacy. 

Purchase full access to the entire 2024 Summit to unlock:

  • All expert interviews with separate audio (MP3) files & transcripts
  • 30 extended, uncut interview editions with hours more expert footage
  • Lifetime on-demand access with no annual fee to 2024 Summit
  • Interview Summaries
  • Treatment Directory & Guidelines
  • And much more!
Order your 2024 Access Pass

Related Talks for: Day 1 (2021)

Why Doesn’t Migraine Have a Cure Yet?

Tissa Wijeratne, MD, FRACP, FAAN

Unlocking the Mystery of Migraine Pathogenesis

Peter Goadsby, MD, PhD, FRS

Finding Resilience With Migraine, Its Comorbidities, and COVID

Noah Rosen, MD, FAHS

The Coalition For Headache And Migraine Patients (CHAMP) is an organization that provides support to people with headache, migraine and cluster diseases who are often stigmatized and under-served.

CHAMP brings together organizations and leaders in this disease area to enhance communication, coordination and collaboration to more effectively help people wherever they are on their patient journey.

CHAMP is working to identify unmet needs of those with headache, migraine and cluster diseases, and will work to better support patients and their caregivers.

Learn more

View more/less

Eli Lilly and Company is proud to sponsor the Migraine World Summit.

Learn more

View more/less

Listen in as world-leading migraine and headache experts share their gratitude for the 60+ patient advocates who help produce the Summit each year.

View more/less

Leave a comment

Back to top